Cite
HARVARD Citation
Cotton, M. et al. (2022). Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial. Lancet infectious diseases. 22 (10), pp. 1472-1483. [Online].